Phase 1 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A neurologist has confirmed a diagnosis of Parkinson's disease (PD) within the last 10 years before the screening visit.
- The person has current or past problems with their digestive system moving slowly, or ongoing constipation.
- The person scores below 3 on a standard scale used to measure how advanced Parkinson's disease symptoms are (the Modified Hoehn and Yahr Scale).
- In the investigator's opinion, the person is able to swallow multiple large capsules without help or difficulty.
- The person has been on a stable dose and schedule of any current prescription medications (except certain Parkinson's medications — see exclusions) or supplements for at least 60 days before joining, and is able to keep those medications unchanged during the study.
- The person has suitable veins that allow blood samples to be taken.
Who may not be able to join:
- The person has a known allergy or sensitivity to any ingredient in the study drug (VT-5006) or placebo, or has a history of serious allergic reactions or anaphylaxis to any drug, food, or other substance.
- The person is taking levodopa/carbidopa or levodopa/benserazide but has not been on a stable dose and schedule for at least 21 days before the first study visit (other Parkinson's treatments may be considered on a case-by-case basis by the medical team).
- The person has a clinically significant abnormal heart rhythm on an ECG, or has a specific heart electrical measurement (corrected QT interval) above 450 ms for males or 470 ms for females.
- The person has significant abnormalities in blood or urine test results, as assessed by the investigator.
- The person has certain liver-related blood test results that are too high — specifically, total bilirubin above 1.5 times the normal upper limit, or liver enzyme levels (ALT or AST) more than twice the normal upper limit (a specific exception may apply for a condition called Gilbert's syndrome — confirm with trial site).
- The person has a history of lower back (lumbar) surgery that, in the investigator's opinion, could interfere with or create risks during a lumbar puncture (spinal tap) procedure.
- The person has any other medical reason that would make a lumbar puncture unsafe or unsuitable (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +31 0715246400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with treatment-related adverse events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.